ʵÑé°¸Àý
²úÆ·ÍÆ¼ö
ÐÂÎÅÍÆ¼ö
Á½°©É¸²éϵͳÓÐʲôÓÅÊÆ£º¹¹½¨Å®ÐÔ¿µ½¡ÖÎÀíµÄÖÇÄÜ·ÀµØ
- 2025-05-20
- / Ô´´
- 130
¡¡¡¡ÔÚ¹«¹²ÎÀÉúÁìÓò£¬£¬£¬£¬ÈéÏÙ°©Ó빬¾±°©×÷ΪÍþвŮÐÔ¿µ½¡µÄÁ½´óɱÊÖ£¬£¬£¬£¬ÆäÔçÆÚɸ²éÊÖÒÕÕýÂÄÀú¸ïÃüÐÔÉý¼¶¡£¡£¡£¡£¡£Á½°©É¸²éϵͳͨ¹ýÕûºÏҽѧӰÏñ¡¢È˹¤ÖÇÄÜ¡¢·Ö×ÓÕï¶ÏµÈÇ°ÑØÊÖÒÕ£¬£¬£¬£¬¹¹½¨ÆðÁýÕÖɸ²é¡¢Õï¶Ï¡¢Ëæ·ÃµÄÈ«Á÷³Ì¿µ½¡ÖÎÀíϵͳ£¬£¬£¬£¬ÏÔÖøÌáÉý°©Ö¢·ÀÖÎЧÄÜ¡£¡£¡£¡£¡£
¡¡¡¡In the field of public health, breast cancer and cervical cancer are two major killers threatening women's health, and their early screening technology is undergoing revolutionary upgrading. The two cancer screening systems integrate cutting-edge technologies such as medical imaging, artificial intelligence, and molecular diagnosis to build a comprehensive health management system covering screening, diagnosis, and follow-up, significantly improving the effectiveness of cancer prevention and treatment.
¡¡¡¡Ò»¡¢ÊÖÒÕÈںϣº¶àģ̬ɸ²é¾ØÕó
¡¡¡¡1¡¢ Technology Fusion: Multimodal Screening Matrix
¡¡¡¡ÏÖ´úÁ½°©É¸²éÏµÍ³Í»ÆÆ¼òµ¥ÊÖÒÕ·¾¶£¬£¬£¬£¬Ðν¨ÉèÌ廯¼ì²âÍøÂ磺
¡¡¡¡The modern two cancer screening system breaks the single technological path and forms a three-dimensional detection network:
¡¡¡¡Ò½Ñ§Ó°ÏñÖÇÄÜ»¯
¡¡¡¡Intelligent medical imaging
¡¡¡¡½ÓÄÉÊý×ÖÈéÏٶϲãºÏ³É£¨DBT£©ÓëÈ˹¤ÖÇÄܶÁƬϵͳ£¬£¬£¬£¬¿Éʶ±ðÖ±¾¶<5mmµÄϸС¸Æ»¯Ôî¡£¡£¡£¡£¡£ÔÚîâ°ÐÓ°ÏñÖУ¬£¬£¬£¬AI¸¨ÖúÕï¶Ïϵͳ¶Ô¶ñÐÔ²¡±äµÄ¼ì³öÂÊ´ï92%£¬£¬£¬£¬½Ï¹Å°åË«ÔÄÆ¬·¨ÌáÉý18¸ö°Ù·Öµã¡£¡£¡£¡£¡£
¡¡¡¡By using digital breast tomography (DBT) and artificial intelligence imaging system, tiny calcifications with a diameter<5mm can be identified. In mammography imaging, the AI assisted diagnostic system has a detection rate of 92% for malignant lesions, which is 18 percentage points higher than the traditional double reading method.
¡¡¡¡·Ö×Ó±ê¼ÇÎï¼ì²â
¡¡¡¡Molecular marker detection
¡¡¡¡Í¨¹ýҺ̬»î¼ìÊÖÒÕ£¬£¬£¬£¬¼ì²âÑ»·Ö×Áöϸ°û£¨CTC£©ÓëÓÎÀëDNA£¨ctDNA£©¡£¡£¡£¡£¡£ÔÚ¹¬¾±°©É¸²éÖУ¬£¬£¬£¬HPV E6/E7 mRNA¼ì²âÁ¬ÏµÏ¸°ûѧ¼ì²é£¬£¬£¬£¬Ê¹¸ß¼¶±ð²¡±äµÄ¼ì³öѸËÙ¶ÈÌáÉýÖÁ95%¡£¡£¡£¡£¡£
¡¡¡¡Using liquid biopsy technology to detect circulating tumor cells (CTCs) and free DNA (ctDNA). In cervical cancer screening, the combination of HPV E6/E7 mRNA detection and cytological examination increases the sensitivity of detecting high-grade lesions to 95%.
¡¡¡¡¶à²ÎÊýÈÚºÏÆÊÎö
¡¡¡¡Multi parameter fusion analysis
¡¡¡¡ÕûºÏ³¬Éùµ¯ÐÔ³ÉÏñ¡¢MRIÀ©É¢¼ÓȨ³ÉÏñ¡¢ÉúÎï±ê¼ÇÎïŨ¶ÈµÈ12Ïî²ÎÊý£¬£¬£¬£¬¹¹½¨°©Ö¢Î£º¦Õ¹ÍûÄ£×Ó¡£¡£¡£¡£¡£ÔÚÈéÏÙ°©É¸²éÖУ¬£¬£¬£¬¸ÃÄ£×Ó¶Ô5Äê·¢²¡Î£º¦µÄÕ¹ÍûAUCÖµ´ï0.89£¬£¬£¬£¬ÊµÏÖΣº¦·Ö²ãÖÎÀí¡£¡£¡£¡£¡£
¡¡¡¡Integrate 12 parameters including ultrasound elastography, MRI diffusion-weighted imaging, and biomarker concentration to construct a cancer risk prediction model. In the screening of breast cancer, the AUC value predicted by the model for 5-year incidence risk reached 0.89, realizing risk stratification management.
¡¡¡¡¶þ¡¢Á÷³ÌÓÅ»¯£ºÉ¸²éЧÂʸïÃü
¡¡¡¡2¡¢ Process optimization: screening efficiency revolution
¡¡¡¡ÏµÍ³Í¨¹ýÁ÷³ÌÔÙÔ죬£¬£¬£¬ÏÔÖøÌáÉýɸ²é¿É¼°ÐÔÓëЧÂÊ£º
¡¡¡¡The system has significantly improved screening accessibility and efficiency through process reengineering
¡¡¡¡×ÔÖú²ÉÑùÖÕ¶Ë
¡¡¡¡Self service sampling terminal
¡¡¡¡°²Åʬ¾±ÍÑÂäϸ°û×Ô²ÉÑù×°±¸£¬£¬£¬£¬ÊܼìÕß¿ÉÔÚÒ½»¤Ö°Ô±Ö¸µ¼ÏÂÍê³ÉÈ¡Ñù¡£¡£¡£¡£¡£Êµ²âÏÔʾ£¬£¬£¬£¬×Ô²ÉÑù±ê±¾ÓëÒ½ÉúÈ¡ÑùµÄϸ°ûѧÇкÏÂÊ´ï98%£¬£¬£¬£¬´ó·ù½µµÍ¶ÔרҵְԱµÄÒÀÀµ¡£¡£¡£¡£¡£
¡¡¡¡Deploy a cervical exfoliated cell self sampling device, and the examinee can complete the sampling under the guidance of medical staff. Actual testing shows that the consistency rate between self sampled specimens and cytology samples taken by doctors is 98%, significantly reducing reliance on professionals.
¡¡¡¡AIÔ¤Õï¶Ïϵͳ
¡¡¡¡AI pre diagnostic system
¡¡¡¡ÔÚÓ°ÏñÉÏ´«ºó£¬£¬£¬£¬AIϵͳ30ÃëÄÚÍê³É²¡ÔλÓëÐÔ×Ó³õÅУ¬£¬£¬£¬±ê×¢¿ÉÒÉÇøÓò¹©Ò½Éú¸´ºË¡£¡£¡£¡£¡£ÔÚÈéÏÙîâ°Ðɸ²éÖУ¬£¬£¬£¬Ê¹Ò½Éú¶ÁƬЧÂÊÌáÉý3±¶£¬£¬£¬£¬Â©ÕïÂÊϽµÖÁ0.5%ÒÔÏ¡£¡£¡£¡£¡£
¡¡¡¡After the image is uploaded, the AI system completes lesion localization and preliminary assessment of its nature within 30 seconds, and marks suspicious areas for doctors to review. In breast mammography screening, the doctor's reading efficiency is increased by three times, and the missed diagnosis rate is reduced to below 0.5%.
¡¡¡¡ÔÆÆ½Ì¨ÖÎÀí
¡¡¡¡Cloud platform management
¡¡¡¡½¨Éèɸ²éÊý¾ÝÔÆÆ½Ì¨£¬£¬£¬£¬ÊµÏÖ¼ì²éÉêÇë¡¢Ó°Ïñ´æ´¢¡¢±¨¸æÌìÉú¡¢Ëæ·ÃÌáÐѵÄÈ«Á÷³ÌÊý×Ö»¯¡£¡£¡£¡£¡£ÔÚÇøÓòɸ²éÏîÄ¿ÖУ¬£¬£¬£¬Ê¹ÖÎÀí±¾Ç®½µµÍ40%£¬£¬£¬£¬Ëæ·ÃÒÀ´ÓÐÔÌáÉýÖÁ85%¡£¡£¡£¡£¡£
¡¡¡¡Establish a screening data cloud platform to digitize the entire process of examination application, image storage, report generation, and follow-up reminders. In the regional screening project, management costs were reduced by 40%, and follow-up compliance was increased to 85%.
¡¡¡¡Èý¡¢¾«×¼¾öÒ飺¸öÌ廯ÕïÁÆÖ§³Ö
¡¡¡¡3¡¢ Accurate decision-making: personalized diagnosis and treatment support
¡¡¡¡ÏµÍ³ÎªÁÙ´²¾öÒéÌṩ¶àάÊý¾ÝÖ§³Ö£º
¡¡¡¡The system provides multidimensional data support for clinical decision-making:
¡¡¡¡Î£º¦·Ö²ãÄ£×Ó
¡¡¡¡Risk stratification model
¡¡¡¡Æ¾Ö¤ÄêËê¡¢¼Ò×åÊ·¡¢É¸²éЧ¹ûµÈ²ÎÊý£¬£¬£¬£¬½«ÊܼìÕß·ÖΪµÍΣ¡¢ÖÐΣ¡¢¸ßΣÈý¼¶¡£¡£¡£¡£¡£¶Ô¸ßΣÈËȺ£¬£¬£¬£¬½¨ÒéËõ¶Ìɸ²é¾àÀëÖÁ6¸öÔ£¬£¬£¬£¬²¢ÄÉÈëÂÌɫתÕïͨµÀ¡£¡£¡£¡£¡£
¡¡¡¡According to parameters such as age, family history, and screening results, the subjects are classified into three levels: low-risk, moderate risk, and high-risk. For high-risk populations, it is recommended to shorten the screening interval to 6 months and include them in the green referral channel.
¡¡¡¡ÖÎÁÆÏìÓ¦Õ¹Íû
¡¡¡¡Treatment response prediction
¡¡¡¡Í¨¹ý»ùÒò¼ì²âÓëÓ°Ïñ×éѧÆÊÎö£¬£¬£¬£¬Õ¹Íûи¨Öú»¯ÁÆÁÆÐ§¡£¡£¡£¡£¡£ÔÚÈéÏÙ°©»¼ÕßÖУ¬£¬£¬£¬¸ÃÄ£×Ó¶Ô²¡ÀíÍêÈ«»º½â£¨pCR£©µÄÕ¹Íû׼ȷÂÊ´ï82%£¬£¬£¬£¬¸¨ÖúÖÆ¶©¸öÌ廯ÖÎÁƼƻ®¡£¡£¡£¡£¡£
¡¡¡¡Predicting the efficacy of neoadjuvant chemotherapy through genetic testing and radiomics analysis. In breast cancer patients, the prediction accuracy of the model for pathological complete remission (pCR) reached 82%, which assisted in the formulation of individualized treatment plans.
¡¡¡¡Ô¤ºóÆÀ¹Àϵͳ
¡¡¡¡Prognostic evaluation system
¡¡¡¡ÕûºÏÖ×Áö¾Þϸ¡¢ÁÜͶºÏ״̬¡¢·Ö×Ó·ÖÐ͵È18ÏîÖ¸±ê£¬£¬£¬£¬¹¹½¨Ô¤ºóÖ¸ÊýÄ£×Ó¡£¡£¡£¡£¡£ÔÚ¹¬¾±°©»¼ÕßÖУ¬£¬£¬£¬¸ÃÄ£×Ó¶Ô5ÄêÉúÑÄÂʵÄÕ¹ÍûÎó²î<5%£¬£¬£¬£¬Ö¸µ¼ÊõºóËæ·ÃÕ½ÂÔ¡£¡£¡£¡£¡£
¡¡¡¡Integrate 18 indicators including tumor size, lymph node status, and molecular typing to construct a prognostic index model. In cervical cancer patients, the prediction error of this model for 5-year survival rate is less than 5%, which guides postoperative follow-up strategies.
¡¡¡¡ËÄ¡¢ÖÊÁ¿¿ØÖÆ£º±ê×¼»¯ÖÎÀíϵͳ
¡¡¡¡4¡¢ Quality Control: Standardized Management System
¡¡¡¡ÏµÍ³Í¨¹ýËÄÖØÖʿػúÖÆ£¬£¬£¬£¬°ü¹Üɸ²éÖÊÁ¿£º
¡¡¡¡The system ensures screening quality through four quality control mechanisms:
¡¡¡¡×°±¸ÐÔÄÜУ׼
¡¡¡¡Equipment performance calibration
¡¡¡¡½ÓÄɱê×¼»¯Ä£Ì壬£¬£¬£¬Ã¿Ô¶ÔÓ°Ïñ×°±¸¾ÙÐÐMTF¡¢DQE¡¢CTÖµÏßÐԵȲÎÊý¼ì²â¡£¡£¡£¡£¡£ÔÚÈéÏÙîâ°Ð»úÖУ¬£¬£¬£¬Ê¹¿Õ¼äÇø·ÖÂÊÎȹÌÔÚ10lp/mmÒÔÉÏ£¬£¬£¬£¬È·±£Ó°ÏñÖÊÁ¿Ò»ÖÂÐÔ¡£¡£¡£¡£¡£
¡¡¡¡Using standardized models, MTF, DQE, CT value linearity and other parameter tests are conducted on imaging equipment on a monthly basis. Stabilize the spatial resolution above 10lp/mm in the breast molybdenum target machine to ensure consistent image quality.
¡¡¡¡Ö°Ô±×ÊÖÊÈÏÖ¤
¡¡¡¡Personnel Qualification Certification
¡¡¡¡½¨Éèɸ²éҽʦ׼ÈëÖÆ¶È£¬£¬£¬£¬Ðèͨ¹ýÈéÏÙ³¬ÉùBI-RADS·ÖÀà¡¢¹¬¾±Ï¸°ûѧTBS±¨¸æµÈרÏîÉóºË¡£¡£¡£¡£¡£ÔÚ¹¬¾±°©É¸²éÖУ¬£¬£¬£¬Ê¹Ï¸°ûѧÕï¶ÏÒ»ÖÂÂÊ´Ó75%ÌáÉýÖÁ92%¡£¡£¡£¡£¡£
¡¡¡¡Establishing a screening physician admission system requires special assessments such as breast ultrasound BI-RADS classification and cervical cytology TBS report. In cervical cancer screening, the consistency rate of cytological diagnosis has been increased from 75% to 92%.
¡¡¡¡Êý¾ÝÖÊÁ¿¼à¿Ø
¡¡¡¡data quality monitoring
¡¡¡¡°²ÅÅÊý¾ÝÏ´åªËã·¨£¬£¬£¬£¬×Ô¶¯Ê¶±ðÂß¼¹ýʧÓëÒì³£Öµ¡£¡£¡£¡£¡£ÔÚɸ²éÊý¾Ý¼Èë»·½Ú£¬£¬£¬£¬Ê¹Êý¾ÝÍêÕûÂÊ´Ó88%ÌáÉýÖÁ99%£¬£¬£¬£¬Òªº¦×Ö¶ÎȱʧÂÊ<0.1%¡£¡£¡£¡£¡£
¡¡¡¡Deploy data cleaning algorithms to automatically identify logical errors and outliers. In the screening data entry process, the data integrity rate was increased from 88% to 99%, and the missing rate of key fields was less than 0.1%.
¡¡¡¡ÊÒ¼äÖÊÆÀÍýÏë
¡¡¡¡Indoor Quality Assessment Plan
¡¡¡¡Ã¿Äê¼ÓÈë¹ú¼Ò²¡ÀíÖÊ¿ØÖÐÐÄ×éÖ¯µÄEQAÍýÏ룬£¬£¬£¬¶Ôϸ°ûѧ¡¢×é֯ѧ¡¢·Ö×Ó¼ì²âµÈÏîÄ¿¾ÙÐÐä·¨ÆÀ²â¡£¡£¡£¡£¡£ÔÚÈéÏÙ°©HER2¼ì²âÖУ¬£¬£¬£¬Ê¹ÊÒ¼ä²î±ðϵÊý£¨CV£©¿ØÖÆÔÚ5%ÒÔÄÚ¡£¡£¡£¡£¡£
¡¡¡¡Participate in the EQA program organized by the National Pathology Quality Control Center every year, conducting blind evaluations of cytology, histology, molecular testing, and other projects. In the detection of breast cancer HER2, the coefficient of ventricular difference (CV) is controlled within 5%.
¡¡¡¡Î塢ЧÀÍÑÓÉ죺ȫÖÜÆÚ¿µ½¡ÖÎÀí
¡¡¡¡5¡¢ Service Extension: Full Cycle Health Management
¡¡¡¡ÏµÍ³Í»ÆÆ¹Å°åɸ²éģʽ£¬£¬£¬£¬¹¹½¨¿µ½¡ÖÎÀí±Õ»·£º
¡¡¡¡The system breaks through the traditional screening mode and builds a closed-loop health management system:
¡¡¡¡ÖÇÄÜËæ·Ãϵͳ
¡¡¡¡Intelligent follow-up system
¡¡¡¡Æ¾Ö¤Î£º¦Æ·¼¶£¬£¬£¬£¬×Ô¶¯ÌìÉú¸öÐÔ»¯Ëæ·ÃÍýÏë¡£¡£¡£¡£¡£¶ÔµÍΣÈËȺ£¬£¬£¬£¬Í¨¹ý¶ÌÐÅÍÆËÍÄê¶Èɸ²éÌáÐÑ£»£»£»£»¶Ô¸ßΣÈËȺ£¬£¬£¬£¬Æô¶¯µç»°Ëæ·ÃÓëר¿ÆÔ¤Ô¼Ð§ÀÍ£¬£¬£¬£¬Ê¹Ëæ·ÃÍê³ÉÂÊÌáÉýÖÁ75%¡£¡£¡£¡£¡£
¡¡¡¡Automatically generate personalized follow-up plans based on risk levels. For low-risk individuals, annual screening reminders will be sent via SMS; For high-risk populations, initiate telephone follow-up and specialist appointment services to increase the completion rate of follow-up to 75%.
¡¡¡¡¿µ½¡µµ°¸¶¯Ì¬¸üÐÂ
¡¡¡¡Dynamic update of health records
¡¡¡¡ÕûºÏɸ²éЧ¹û¡¢ÕïÁƼͼ¡¢ÉúÑÄ·½·¨µÈÊý¾Ý£¬£¬£¬£¬ÌìÉú¶¯Ì¬¿µ½¡»Ïñ¡£¡£¡£¡£¡£ÔÚÈéÏÙ°©»¼ÕßÖУ¬£¬£¬£¬Í¨Ì«¹ýÎöÌåÖØÖ¸Êý¡¢Ô˶¯Ï°¹ßµÈ²ÎÊý£¬£¬£¬£¬Ê¹¸´·¢Î£º¦Õ¹Íû׼ȷÂÊÌáÉý30%¡£¡£¡£¡£¡£
¡¡¡¡Integrate screening results, diagnosis and treatment records, lifestyle and other data to generate dynamic health profiles. In breast cancer patients, through the analysis of body mass index, exercise habits and other parameters, the accuracy of recurrence risk prediction increased by 30%.
¡¡¡¡¿µ½¡½ÌÓýƽ̨
¡¡¡¡Health Education Platform
¡¡¡¡¿ª·¢½»»¥Ê½¿µ½¡½ÌÓýÄ£¿£¿£¿£¿é£¬£¬£¬£¬Ìṩ°©Ö¢·ÀÖÎ֪ʶ¡¢ÐÄÀíÊèµ¼¡¢ÓªÑøÖ¸µ¼µÈÄÚÈÝ¡£¡£¡£¡£¡£ÔÚ¹¬¾±°©É¸²éÏîÄ¿ÖУ¬£¬£¬£¬Ê¹¿µ½¡ÖªÊ¶ÖªÏþÂÊ´Ó65%ÌáÉýÖÁ90%£¬£¬£¬£¬É¸²é¼ÓÈëÒâÔ¸ÔöÇ¿2.3±¶¡£¡£¡£¡£¡£
¡¡¡¡Develop an interactive health education module that provides knowledge on cancer prevention and treatment, psychological counseling, nutritional guidance, and other related content. In the cervical cancer screening program, the awareness rate of health knowledge has increased from 65% to 90%, and the willingness to participate in screening has increased by 2.3 times.
¡¡¡¡Á½°©É¸²éϵͳµÄÓÅÊÆ£¬£¬£¬£¬ÊÇÊÖÒÕ¾«¶È¡¢ÖÎÀíЧ¶ÈÓëЧÀÍζȵÄÓлúͳһ¡£¡£¡£¡£¡£Í¨¹ý¹¹½¨ÖÇÄÜ»¯¡¢±ê×¼»¯¡¢È«ÖÜÆÚµÄ¿µ½¡ÖÎÀíϵͳ£¬£¬£¬£¬ÏµÍ³²»µ«ÌáÉý°©Ö¢ÔçÕïÂÊ£¬£¬£¬£¬¸üÍÆ¶¯¹«¹²ÎÀÉúЧÀÍÏòÔ¤·ÀΪÖ÷¡¢¾«×¼¸ÉÔ¤µÄÆ«ÏòתÐÍ¡£¡£¡£¡£¡£ÕâÖÖÁ¢Òìģʽ£¬£¬£¬£¬ÕýÔÚÖØËÜÅ®ÐÔ¿µ½¡ÖÎÀíµÄ·¶Ê½£¬£¬£¬£¬ÎªÏû³ý°©Ö¢ÍþвÌṩ¿Æ¼¼Ö§³Ö¡£¡£¡£¡£¡£
¡¡¡¡The advantages of the two cancer screening systems are the organic unity of technical accuracy, management effectiveness, and service temperature. By building an intelligent, standardized, and full cycle health management system, the system not only improves the early diagnosis rate of cancer, but also promotes the transformation of public health services towards prevention oriented and precise intervention. This innovative model is reshaping the paradigm of women's health management and providing technological support for eliminating the threat of cancer.
¡¡¡¡±¾ÎÄÓÉÁ½°©É¸²éϵͳÓÑÇé¹±Ï×.¸ü¶àÓйصÄ֪ʶÇëµã»÷:ÎÒÃǽ«»á¶ÔÄúÌá³öµÄÒÉÎʾÙÐÐÏêϸµÄ½â´ð£¬£¬£¬£¬½Ó´ýÄúµÇÂ¼ÍøÕ¾ÁôÑÔ.
¡¡¡¡This article is a friendly contribution from the occupational disease examination system For more information, please click: We will provide detailed answers to your questions. You are welcome to log in to our website and leave a message